U.S. Grants Vidac Pharma Patent For Oncology Drug Candidates
19 Sep 2024 //
GLOBENEWSWIRE
Vidac Pharma Releases Results Of Next-Gen Drug Tests In Tumor Models
24 Jul 2024 //
GLOBENEWSWIRE
Vidac Pharma Gets Patent Allowance For Cancer Drug Compounds
03 Jun 2024 //
GLOBENEWSWIRE
Vidac Pharma receives Japanese Patent Office Notice of Allowance for VDA-1275
27 Mar 2024 //
GLOBENEWSWIRE
Vidac secures approval for study of lead asset in Cutaneous T-Cell Lymphoma
12 Mar 2024 //
GLOBENEWSWIRE
Vidac Pharma presents high efficacy in multiple solid tumor models
19 Feb 2024 //
GLOBENEWSWIRE
Vidac Pharma reports positive interim Phase 2a data in VDA-1102
29 Jan 2024 //
GLOBENEWSWIRE
Vidac Pharma to conduct Phase 2b study for VDA-1102
19 Dec 2023 //
GLOBENEWSWIRE